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Human proximal tubule epithelial 
cells cultured on hollow fibers: 
living membranes that actively 
transport organic cations
J. Jansen1,2,3, I. E De Napoli4, M. Fedecostante1,2,3, C. M. S. Schophuizen1,2,3, 
N. V. Chevtchik4, M. J. Wilmer1, A. H. van Asbeck5, H. J. Croes6, J. C. Pertijs1, 
J. F. M. Wetzels7, L. B. Hilbrands7, L. P. van den Heuvel3,8, J. G. Hoenderop2,  
D. Stamatialis4 & R. Masereeuw1,9
The bioartificial kidney (BAK) aims at improving dialysis by developing ‘living membranes’ for 
cells-aided removal of uremic metabolites. Here, unique human conditionally immortalized 
proximal tubule epithelial cell (ciPTEC) monolayers were cultured on biofunctionalized MicroPES 
(polyethersulfone) hollow fiber membranes (HFM) and functionally tested using microfluidics. Tight 
monolayer formation was demonstrated by abundant zonula occludens-1 (ZO-1) protein expression 
along the tight junctions of matured ciPTEC on HFM. A clear barrier function of the monolayer 
was confirmed by limited diffusion of FITC-inulin. The activity of the organic cation transporter 2 
(OCT2) in ciPTEC was evaluated in real-time using a perfusion system by confocal microscopy using 
4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) as a fluorescent substrate. Initial ASP+ 
uptake was inhibited by a cationic uremic metabolites mixture and by the histamine H2-receptor 
antagonist, cimetidine. In conclusion, a ‘living membrane’ of renal epithelial cells on MicroPES HFM 
with demonstrated active organic cation transport was successfully established as a first step in BAK 
engineering.
The development of biotechnological platforms to aid uremic syndrome treatment is of high interest 
world-wide. Current treatment strategies, such as hemo- or peritoneal dialysis, demonstrate a poor clear-
ance of small lipid soluble and protein-bound uremic metabolites and the mortality rate in patients 
suffering from renal disease remains high1. The uremic syndrome is characterized by the retention of 
metabolites due to an attenuated filtration capacity of the glomerulus and a loss of function of proxi-
mal tubule epithelial cells (PTEC), which are responsible for active metabolite secretion. Elevated lev-
els of retention solutes contribute to competitive inhibition of drug transporters and thereby alter the 
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metabolic environment as well as drug disposition in the kidney2,3. The accumulation of uremic metab-
olites (i.e. uremic toxins) in the human body may contribute to further progression of renal disease and 
the association of chronic kidney disease with cardiovascular morbidity4–6.
A cell-aided device containing stable living membranes, which enable active transport of uremic 
metabolites would be a major breakthrough in the field of regenerative nephrology. Nowadays, various 
research groups are focussed on the development of a bioartificial kidney (BAK), containing PTEC to 
improve current treatment strategies7–9. In uremic animals and patients suffering from acute kidney 
injury (AKI) encouraging results have been obtained with respect to enhanced survival in BAK treated 
subjects by reduction of the inflammatory status, but further extensive research is required to obtain 
stable and functional cell-aided devices for chronic use9–13. A crucial step in the development of func-
tional devices relates to advanced functionalization of the hollow fiber membranes (HFM) to stimulate 
monolayer formation. In vivo, the extracellular matrix (ECM) is key in inter- and intracellular signaling, 
regeneration, and support14,15. Mimicking this complex matrix to obtain well-differentiated PTEC mon-
olayers in vitro is essential in BAK engineering. Successful PTEC monolayer formation was obtained 
using combinations of laminin, gelatin, matrigel, collagen IV and L-3,4-dihydroxydiphenylalanine 
(L-DOPA) ECM coatings on biomaterials16–18. However, active transport of uremic metabolites medi-
ated by PTEC specific transporters on hollow fiber membranes to aid renal replacement therapy has, as 
of yet, not been demonstrated.
In addition to glomerular filtration, the renal excretion of endo- and xenobiotics is advanced by 
active tubular secretion, a process mediated by PTEC, which are equipped with a broad range of trans-
porters. One of the main PTEC transporters involved in the uptake of cationic uremic metabolites and 
drugs, such as cimetidine, metformin and cisplatin19–21, is the basolateral organic cation transporter - 2 
(OCT2; SLC22A2). Various cationic uremic metabolites, including guanidino compounds and polyam-
ines, were found to interact with this transporter as well22. Guanidino compounds are derived from 
the arginine metabolism and are small, water-soluble cations and not bound to proteins4. However, the 
effective removal of guanidines is hampered in uremic conditions particularly due to their large distri-
bution volume23. Guanidines are known neurotoxins24, but more recently the pro-inflammatory effects 
on the expression of leukocyte surface molecules and thus the possible interference of leukocytes with 
endothelial cells resulting in cardiovascular events was demonstrated as well25,26. Polyamines, derived 
from cellular lysine, arginine or ornithine catabolism, were identified in the late ‘70s as putative cati-
onic uremic metabolites by Campbell et al.27. More recent work elucidated further that the polyamines 
cadaverine, putrescine, spermine, spermidine and their breakdown product acrolein accumulate in ure-
mic patients and are associated with cytotoxicity, through damage to proteins, DNA and other cellular 
components28–30.
In our laboratory, a unique conditionally immortalized PTEC model (ciPTEC) derived from human 
urine was established and thoroughly characterized31,32. These cells contain the temperature sensitive vec-
tor SV40tsA58, allowing proliferation at 33 °C and differentiation in mature PTEC at 37 °C. In addition, 
cells were transfected with human telomerase (hTERT) limiting replicative senescence by telomere length 
maintenance, improving further the unlimited availability of ciPTEC. This model presents a broad range 
of PTEC-specific functions, including the transporters associated with uremic toxin secretion along with 
drug metabolism enzymes22,31,33. In the present study, ciPTEC monolayer function when cultured on 
MicroPES HFM was investigated as a crucial element of a renal assist device. To this end, permeability 
properties of (biofunctionalized) membranes, monolayer formation and epithelial functional character-
istics were investigated. The latter included OCT2 activity assessment using a microfluidic system with 
real-life imaging in the presence or absence of OCT2 inhibitors as well as a cationic uremic metabolites 
mixture of guanidines and polyamines.
Results
Modified HFM maintain membrane permeability. The surface of MicroPES HFM was function-
alized via a double coating to enable tight homogeneous cell monolayer formation. The coating was suc-
cessfully developed in 2D by our group using Transwell® membrane supports18. Here, this was optimized 
further in 3D. The membrane surface and cross sections of uncoated and coated HFM in the absence 
of cells were investigated using SEM (Fig. 1A,B). In agreement with our previous study18, the coatings 
applied were thin and did not differ between fibers, consistent with their transport properties. The coated 
HFM should facilitate transepithelial transport of protein-bound uremic toxins, with retained solute per-
meability. As shown in Fig. 1C, the H2O permeability was preserved in double coated HFM ((16.4 ± 0.7) . 
103 L m−2 h−1bar−1) compared to uncoated HFM ((17.0 ± 0.3) . 103 L m−2 h−1bar−1). In addition, both 
IgG and BSA passed almost freely through the membrane as demonstrated by the sieving coefficient 
(SC) close to 1 for both coated (0.90 ± 0.01 and 0.97 ± 0.02, respectively; p < 0.01) and uncoated HFM 
(0.97 ± 0.02 and 0.98 ± 0.01, respectively) (Fig.  1D). Obviously, the final composition of coated HFM 
with a tight cell monolayer should form a true barrier and prevent the loss of essential components such 
as IgG and albumin into the dialysate.
Extracellular matrix, cellular adhesion and paracellular permeability. Collagen IV is a 
non-fibrillar collagen and is known to assist in cell differentiation towards renal lineages from various 
stem cell populations34. The presence of a collagen IV matrix after the coating procedure was confirmed, 
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as shown in Fig.  2A,B, though a heterogeneous pattern was observed. Interestingly, in the presence of 
matured ciPTEC, a nice homogeneous collagen IV matrix was visible (Fig. 2C,D). Moreover, cell adhe-
sion clearly improved upon surface modification, as shown in Fig. 2E, suggesting biofunctionalization. 
Hardly any nuclei (i.e. cells) were detected when cultured on uncoated HFM, whereas a uniform dis-
tribution of nuclei was observed after double coating. Furthermore, the transepithelial barrier function 
was quantified by inulin-FITC diffusion after perfusion of HFM in the presence or absence of matured 
ciPTEC. As shown in Fig. 2F, matured ciPTEC formed a true barrier compared to coated HFM in the 
absence of cells (373 ± 42 pmol min−1 cm−2; 1200 ± 193 pmol min−1 cm−2, respectively, p < 0.001). In 
addition, cell adhesion of ciPTEC to PES HFM was found to be related to the curvature of the mem-
brane. Similar double coating procedures applied to PES HCO 1100 membranes with an inner diameter 
of 215 μ m resulted in poor ciPTEC adherence (Figure S2), in contrast to double coated MicroPES HFM 
with an inner diameter of 300 μ m (Fig. 2).
Intact cellular organelles and numerous microvilli. Matured ciPTEC cultured on HFM retained 
intact cellular organelle morphology as observed by TEM (Fig.  3A). The presence of numerous mito-
chondria indicated that the cell monolayer consists of viable and metabolically active PTEC35. Moreover, 
other essential cellular components, including the Golgi apparatus, endoplasmatic reticulum, ribosomes, 
the nucleus and its chromatin, could be determined. The brush border membrane of ciPTEC is reason-
ably well-developed, containing many microvilli to enlarge the apical surface and to stimulate intensive 
reabsorption, as observed with SEM (Fig. 3B).
Homogenous cell monolayers represent ZO-1 and OCT2 expression. The presence of the tight 
junction protein ZO-1 in cell monolayers emphasizes cell polarity and monolayer tightness. In addition, 
tight junction proteins contribute to fluid and ion homeostasis mediated by paracellular transport36. A 
tight homogeneous cell monolayer was observed for ciPTEC on HFM with ZO-1 abundantly expressed 
along the cell boundaries as shown in representative z-scans (Fig.  4A,C). Moreover, the endogenous 
expression of the influx transporter OCT2 was demonstrated to be expressed basolaterally (Fig.  4D), 
although some cytoplasmic staining was visible as well, suggesting ongoing posttranslational OCT2 mod-
ifications as previously suggested37. The OCT2 antibody was validated in paraffin embedded human 
Figure 1. HFM topography and flux of essential compounds. (A,B) Representative SEM images of 
uncoated and coated MicroPES HFM are shown. No microscopic differences were observed and topography 
was preserved in coated HFM. (C) The water permeance of uncoated and coated HFM was highly similar 
in both conditions (U: (17.0 ± 0.3) . 103 Lm−2 h−1bar−1) vs. C: (16.4 ± 0.7) . 103 Lm−2 h−1bar−1, respectively). 
(D) The SC of IgG was slightly less in coated HFM (C: 0.90 ± 0.01, p < 0.01) compared to uncoated HFM 
(U: 0.97 ± 0.02), whereas BSA passed almost freely through the membrane as demonstrated by the SC close 
to 1 for coated (C: 0.97 ± 0.02) and uncoated HFM (U: 0.98 ± 0.01). Data are shown as mean ± S.E.M. of 
three independent experiments performed in duplicate ** p < 0.01 using an unpaired t test.
www.nature.com/scientificreports/
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Figure 2. Extracellular matrix, cellular adhesion and paracellular permeability. Representative confocal 
images of collagen IV (green) in y-z (A,C) and x-y (B,D) planes are shown. (A,B) A heterogeneous collagen 
IV ECM pattern was detected on coated HFM without cells. (C,D) Nuclei were stained using DAPI (blue) in 
matured ciPTEC cultured on coated HFM. A homogenous and abundant distribution of collagen IV (green) 
was detected in the presence of matured ciPTEC. (E) Representative images of adhered cells (matured 
ciPTEC) are shown by nuclei staining (dapi; blue). A limited number of cells were present when cultured on 
uncoated HFM whereas numerous cells adhered to the coated HFM surface. (F) The transepithelial barrier 
function was examined in the presence or absence of matured ciPTEC by inulin-FITC perfusion and the 
flux across the HFM was quantified. Data are shown as mean ± S.E.M. of three independent experiments 
performed in triplicate or duplicate. *** p < 0.001 using an unpaired t test.
www.nature.com/scientificreports/
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kidney tissue using immunohistochemistry and positive staining at the basolateral membrane of PTEC 
was observed (data not shown).
ciPTEC on HFM show functional OCT2 transport. The activity of basolaterally expressed OCT2 
in matured ciPTEC cultured on coated HFM was determined by real-time fluorescent ASP+ uptake 
measurements, and shown in Fig.  5. The experiments were performed in the presence or absence of a 
cationic toxin mix or cimetidine, which are known inhibitors of OCT2-mediated ASP+ transport22. In 
Fig. 5A, representative real-time uptake images of the various conditions are shown for the time frame 
Figure 3. Cellular organelles and surface characteristics. (A) The morphology of organelles in matured 
ciPTEC cultured on HFM (H) was investigated by transmission electron microscopy and intact cells were 
detected. Next to numerous well-developed mitochondria, the nucleus (N) containing the chromatin 
(Ch), the endoplasmatic reticulum (E), ribosomes (R) and the Golgi apparatus could be nicely detected. 
(B) The surface of matured ciPTEC was visualized using scanning electron microscopy. At the apical 
membrane microvilli were observed, as expected for proximal tubule epithelial cells, though a heterogeneous 
distribution was detected.
www.nature.com/scientificreports/
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of 4–13 min. In the absence of inhibitors, a clear intracellular fluorescent ASP+ signal was visible after 
4 min of perfusion, which increased up to 13 min. In the presence of the cationic uremic toxin mixture 
of guanidine and polyamine compounds, the basal uptake of ASP+ was still detectable and augmented 
over time, though the uptake was less pronounced compared to fiber perfusion in absence of the mix-
ture. In the presence of cimetidine, the ASP+ uptake was even further attenuated. Semi-quantification of 
these data (Fig. 5B) confirmed the observed differences in ASP+ uptake per condition. The slopes from 
the linear part (min 1–8) of ASP+ uptake curves in the presence of the cationic toxin mix or cimetidine 
were significantly altered compared to control uptake (25 ± 16%, p < 0.001 and 62 ± 12%, p < 0.001, 
respectively).
Figure 4. ZO-1 and OCT2 protein expression. Representative confocal images of ZO-1 (green), OCT-2 
(red) and nuclei (blue) in matured ciPTEC cultured on HFM are shown in x-y and y-z planes. (A–C,E) 
The ZO-1 expression was abundantly present along the cell boundaries within a tight and homogenous cell 
monolayer. (D,E) The endogenous OCT-2 protein expression in ciPTEC was observed heterogeneously in 
the membranes, moreover, some signal was detected in the cytoplasm.
www.nature.com/scientificreports/
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Discussion
In this study, ciPTEC were successfully cultured on optimally coated HFM with maintained functionality. 
The coating and membrane curvature showed to be crucial for the formation of a homogenous cell mon-
olayer with a clear epithelial barrier function, without affecting transport properties of H2O or albumin. 
Epithelial cell polarity and organelle morphology were retained when cultured on HFM. In addition, the 
epithelial and polarized characteristics of ciPTEC were demonstrated further by the expression of ZO-1 
and the basolaterally expressed OCT2. Transport activity was confirmed by specific uptake in ciPTEC 
monolayers, demonstrating the establishment of a living membrane suitable for BAK development.
The MicroPES membranes used in this study are hydrophilized fibers used predominantly for plasma 
separation and have rather large pores allowing the transport of proteins including BSA and IgG. The 
membranes are designed for having low interaction with blood, plasma and proteins. To apply a uniform 
Figure 5. Functional organic cation transporter - 2 transport. (A) Representative real-time images and 
(B) semi-quantification of ASP+ uptake (10 μ M, green) are shown, a model substrate for OCT-2, in the 
absence (circle) or presence of specific inhibitors (triangle: cationic uremic toxin mix (UTmix), square: 
cimetidine (100 μ M)) in matured ciPTEC cultured on HFM. Data were normalized against ASP+ uptake in 
the absence of inhibitors and were fitted according to One-phase exponential association using nonlinear 
regression analysis. (a - circle) After 4 min, intracellular ASP+ signal could be visualized and further 
increased until 13 min. (a - triangle) In the presence of UTmix the ASP+ uptake was less pronounced during 
the complete uptake experiment compared to perfusion with only ASP+. (a - square) The ASP+ uptake was 
clearly attenuated in the presence of cimetidine and hardly any further increase in fluorescent ASP+ uptake 
was detected after 7 min. (B) Semi-quantification of ASP+ uptake data in the absence (10 μ M, circle) or 
presence of specific inhibitors (triangle: cationic uremic toxin mixture (UTmix, (10× )), square: cimetidine 
(100 μ M) in matured ciPTEC cultured on HFM are shown. A clear fluorescent intracellular signal in ciPTEC 
indicated an active OCT-2 mediated basal ASP+ uptake started at 1 min. Initial uptake was significantly 
inhibited by the UT mixture and cimetidine. Data are shown as mean ± S.E.M. of three independent 
experiments performed in duplicate. Slopes extracted from min 1–8 of the ASP+ uptake in different 
conditions were compared and applied for statistical analysis. ***p < 0.001 using two-way ANOVA analysis 
followed by Bonferroni post-tests.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:16702 | DOI: 10.1038/srep16702
cell monolayer, the outer membrane of HFM had to be biofunctionalized by ECM components. The 
native ECM is a dynamic network consisting of various types of collagen, glycosaminoglycans, laminin 
and fibronectin connected to integrins present in the plasma membrane. The ECM is a key factor in 
cell adhesion, differentiation and regeneration, as well as in intercellular signalling14,15. Oo et al. demon-
strated a successful coating on PES membranes consisting of the combination of L-DOPA and collagen 
IV to culture primary human renal cells38. Upon polymerization, when exposed to light and oxygen, 
the L-DOPA layer becomes negatively charged and will attract the positively charged collagen IV that is 
applied subsequently. In our laboratory, this coating was first applied on flat PES membranes and optimal 
conditions for ciPTEC adhesion and differentiation were established18. Maintained membrane perme-
ability, as well as homogenous cell monolayers and creatinine transport were demonstrated in ciPTEC 
on double coated PES flat membranes. Based on these encouraging results, the coating was adapted for 
HFM biofunctionalization. Both L-DOPA and collagen IV coating times were extended to hours instead 
of minutes to stimulate cell adhesion and tight cell monolayer formation. Next to an optimized ECM, 
the membrane curvature is an important parameter for maintaining cellular functions39. The culture of 
ciPTEC on MicroPES HFM with a slightly lower membrane curvature compared to the HCO 1100 HFM 
had a positive effect on cell adhesion, most likely related to a more optimal organization of the cytoskel-
eton and its membrane composition. The almost unrestricted permeability of H2O, IgG and albumin 
in coated MicroPES HFM indicated the need for a tight cell monolayer with a true barrier function to 
avoid significant blood components loss from the host. Hence, the free permeability of albumin across 
coated HFM is essential, as a large number of uremic toxins are protein-bound and need to be delivered 
in close proximity to the cells in order to be eliminated. Possible immunogenic effects due to contact 
between the host blood components and cell monolayers will be studied thoroughly in future research.
The morphological characteristics of tight cell monolayers on HFM were examined, as well as the 
epithelial barrier functions. In vivo, the proximal tubule epithelium is known as a leaky epithelium and 
paracellular transport is mediated along the tight junctions and lateral inter-cellular spaces35. The reab-
sorption of glucose, amino acids, H2O and electrolytes is partly facilitated by paracellular transport and 
occurs in a passive manner. The abundant expression of the tight junction protein ZO-1 in the monolay-
ers emphasized the epithelial character of the ciPTEC when cultured on HFM. Moreover, the epithelial 
barrier function was confirmed by demonstrating limited inulin-FITC diffusion. Since technical aspects 
of fiber handling when placed in the perfusion chamber will affect the tightness of the cell layer, the 
barrier restriction measured, as shown here, is most likely an underestimation. To prevent monolayer 
disturbance caused by technical aspects in future research, cell culture on HFM could be performed 
in disposable perfusion chambers. In this way, the cells on HFM will mature while already present in 
the system and will be ready-to-use for any perfusion experiment. Vital PTEC possess a high number 
of mitochondria to facilitate active processes (e.g. elimination of waste products) and a well-developed 
brush border membrane containing microvilli to enlarge the apical surface35. The morphology of ciPTEC 
reflected the presence of intact organelles and a substantial number of mitochondria. The microvilli at the 
apical surface were visible when ciPTEC were cultured on HFM, but showed a heterogeneous pattern. 
Further optimization of culture conditions in disposable perfusion chambers, including medium flow 
across the apical membrane, could improve the uniformity of the ciPTEC brush border membrane40.
The application of a cell-aided device, such as the BAK, for the removal of cationic metabolites can 
improve current renal replacement therapies. In this study, active OCT2 transport was demonstrated in 
living membranes of human PTEC when cultured on HFM for BAK purposes. Uptake via the OCT2 
transporter is the first step in the renal secretion of various cationic endogenous metabolites or other 
xenobiotics, including drugs41. Upon transport failure, accumulation of cationic metabolites, such as 
guanidines occurs. This is associated with cardiovascular implications, induced by, amongst others, acti-
vated leukocytes and microinflammation25,26. Here, OCT2-mediated ASP+ uptake was inhibited in the 
presence of a polyamine and guanidino cationic uremic toxin mixture, as well as in the presence of 
cimetidine, a well-known and extensively studied renal OCT substrate and inhibitor42,43. These findings 
indicate functional OCT2 transport in ciPTEC on HFM, in concordance with recently described obser-
vations by Schophuizen et al., where the cationic toxin mixture competed with OCT2-mediated ASP+ 
uptake in a ciPTEC cell suspension22. In addition, Kimura and Winter et al. demonstrated interference of 
guanidino compounds and putrescine, a polyamine, with OCT2 using human embryonic kidney cell line 
(HEK293) overexpressing the transporter44,45. The application of functional ciPTEC cultured on HFM 
opens a promising avenue in the clearance of cationic metabolites in patients suffering from renal disor-
ders. Future research is required to quantify transepithelial transport of uremic metabolites in up-scaled 
multifiber bioreactors. As (cationic) uremic toxins compete for the same system, their accumulation may 
also hamper efficient removal. Therefore, in-depth kinetic studies are needed to investigate the clearance 
capacity of our bioartificial tubule over time, and to predict their performance in vivo. In addition, other 
aspects, such as the balance between the number of ciPTEC and the duration per dialysis cycle required 
for efficient removal of waste products in human patients, have to be investigated.
The development of a functional and stable BAK device is a complex interplay between advanced bio-
materials and renal epithelial cells. Beneficial effects were demonstrated in uremic animals and enhanced 
survival of patients suffering from multi-organ failure and AKI in a phase II clinical trial. However, a 
phase IIb clinical trial failed predominantly due to hampered cell performance9–13,46. In the late ‘90s, 
Humes et al. cultured porcine proximal tubule epithelial cells (LLC-PK1) in a multi-fiber bioreactor 
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and demonstrated metabolically active cells, capable of ammoniagenesis, glutathione metabolism and 
1,25-dihydroxyvitamin D3 synthesis47. However, next to its non-human origin, porcine cells have limited 
transport functionality (e.g. lack of essential transporters48,49) and are not preferred for use in a BAK 
device. Only a few human-derived cell models are available with endogenous transporter expression and 
functional capacity. A well-distributed cell line is HK2, which was developed by recombinant retroviral 
transduction (humanpapillomavirus 16 E6/E7 genes) of human primary renal cortex cells50, though a 
lack of functional transporters emphasizes the limitations of this model for studying renal transport in 
pharmacological and physiological studies51. The thoroughly characterized cell model ciPTEC, as used in 
this study, was isolated from human urine and immortalized using retroviral hTERT and SV40 large T 
antigen transduction32. The cell model displays diverse functional endogenous in- and efflux transporters 
relevant in the secretion of endo- and xenobiotics31,32. In addition, UDP-glucuronosyltransferases (UGT) 
and mitochondrial succinate dehydrogenase enzyme activity was confirmed and altered in uremic con-
ditions that might affect drug disposition during CKD33. Similar to HK-2, no organic anion transporter 
(OAT) expression could be detected in ciPTEC, a known phenomenon of immortal renal cells in culture 
and a drawback of renal cell line applications52. Nevertheless, the stable functionality of other relevant 
transporters and metabolic enzymes in ciPTEC upon prolonged culturing illustrate that these cells may 
prove a valuable tool in regenerative nephrology. Furthermore, this model may serve as a predictive 
model for drug toxicity screening in drug development processes.
To treat patients suffering from CKD or end-stage renal disease (ESRD), an efficient removal of 
protein-bound uremic toxins by a BAK is a prerequisite to diminish systemic disease progression53. The 
active transport of cationic uremic toxins mediated by ciPTEC, as shown here, is an important contri-
bution for future BAK engineering. However, future research is required to study the maintenance of 
functional cationic and anionic toxin transport in an up-scaled BAK system, as well as multi-factorial 
safety aspects, as described by the European medicines agency in the European guidelines for advanced 
therapy medicinal products enabling the applications of GMO in medicinal products54.
In conclusion, a successful cell monolayer formation was established on biofunctionalized MicroPES 
HFM and matured ciPTEC represented clear epithelial characteristics with barrier and active transporter 
function. To the best of our knowledge, for the first time active organic cationic transport in PTEC 
monolayers on HFM was demonstrated. The combination of a unique human cell model with biofunc-
tionalized MicroPES HFM is a valuable tool in regenerative nephrology and further development may 
contribute in future BAK engineering.
Methods
Brief methods are given. For details, the reader is referred to Supplementary materials.
Chemicals and cell culture materials. Chemicals were purchased from Sigma-Aldrich (Zwijndrecht, 
The Netherlands) unless stated otherwise. MicroPES type TF10 hollow fiber capillary membranes (wall 
thickness 100 μ m, inner diameter 300 μ m, max pore size 0.5 μ m) were obtained from Membrana GmbH 
(Wuppertal, Germany). Cell culture plates were purchased from Greiner Bio-One (Monroe, NC).
Hollow fiber sterilization and double coating. MicroPES (polyethersulfone) hollow fiber mem-
branes were sterilized using 70% (v/v) EtOH incubation for 30 min. The primary coating component 
L-DOPA (L-3,4-dihydroxyphenylalanine, 2 mg.ml−1) was dissolved in 10 mM Tris buffer (pH 8.5), as 
described previously by Ni et al.16, at 37 °C for 45 min. Next, the solution was filter sterilized prior to 
incubation of the horizontally placed fibers for 5 hours at 37 °C. The L-DOPA coated fibers were exposed 
to the second coating component human collagen IV (C6745-1 ml, 25 μ g.ml−1) for 1 hour at 37 °C. The 
collagen IV solution was aspirated afterwards and the fibers were washed thoroughly in HBSS buffer 
prior to cell seeding.
Scanning electron microscopy of cell-free hollow fiber membranes. Membrane topography of 
uncoated and coated HFM was determined using scanning electron microscopy (SEM) analysis (Philips 
XL-30 ESEM, Amsterdam, the Netherlands). In short, HFM were prepared using liquid nitrogen fracture 
to enable cross section analysis. Samples were incubated at 37 °C overnight and gold sputtered before 
examination by SEM (3 kV and 5 kV).
Transport properties of cell-free hollow fibers membranes. The transport of pure water (Merck 
MilliPore, Billerica, MA), bovine serum albumin (BSA) and immunoglobulin G (IgG) solutions through 
the uncoated and coated cell-free HFMs were measured at various transmembrane pressures using a 
KrosFlo Research IIi Tangential Flow Filtration system (Spectrum laboratories, Wurzburg, Germany). 
The membrane permeability of H2O was plotted as the slope of the flux versus the transmembrane pres-
sure. The membrane sieving coefficient (SC) was calculated by dividing the concentration of the BSA and 
IgG in the permeate by the concentration of the feed protein solution.
Culture of ciPTEC on double coated hollow fiber membranes. Proliferating ciPTEC32 were 
seeded on double-coated fibers (length 2 cm) using 1.5 × 106 cells per 1.5 ml. The cell suspension was 
added to an eppendorf tube containing the fiber and incubated at 33 °C, 5% (v/v) CO2, for 4 hours. Every 
www.nature.com/scientificreports/
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hour the tube was turned 90° in order to stimulate cell adhesion to the whole surface. Next, fibers with 
adhered cells were removed from the suspension and transferred to a 6 well plate with PTEC culture 
medium and were cultured as previously described by Jansen et al.31.
Immunocytochemistry. The expression of OCT2, zonula occludens-1 (ZO-1) and the ECM com-
ponent collagen IV in ciPTEC monolayers on hollow fibers were investigated using the immunocyto-
chemistry methodology as previously described by Jansen et al.31. The expression and localization of the 
proteins of interest were examined using the Olympus FV1000 Confocal Laser Scanning Microscope 
(Olympus, Tokyo, Japan) and images were captured using the Olympus software FV10-ASW version 1.7.
Transmission- and scanning electron microscopy. The morphology of ciPTEC and its organelles 
was investigated using transmission electron microscopy (TEM) and SEM. In short for TEM, cells were 
fixed and dehydrated using series of chemical solutions and finally embedded in Epon and polymerized 
at 60 °C. After ultrathin sectioning and contrasting with uranyl acetate and lead citrate, sections were 
analyzed using a transmission electron microscope JEOL JEM 1010 (Jeol, Akishima Tokyo, Japan). For 
SEM purposes, cells were fixed and dehydrated using various chemical solutions and finally critical point 
dried. Samples were gold sputtered prior to SEM analysis (JEOL JSM-6340F, Tokyo, Japan).
Transepithelial barrier function. Paracellular permeability was determined in the living membrane 
by endpoint quantification of inulin-fluorescein isothiocyanate (FITC) (0.1 mg.ml−1 in Krebs-Henseleit 
buffer) supplemented with HEPES (10 mM; KHH buffer)) diffusion when perfused (6 ml.h−1, in close 
agreement with previously applied flow rates8) using a custom-made microfluidic system (supplemental 
figure S1) connected to a syringe pump (Terumo STC-521, Terumo Europe N.V., Leuven, Belgium) 
for 13 min at 37 °C. As a control, the inulin-FITC diffusion in coated HFM in the absence of cells was 
investigated in similar conditions. Fluorescence was detected by measuring samples and a standard range 
(0.0005–0.1 mg/ml, including a final blank sample (KHH buffer) 100 μ l) at excitation wavelength 485 nm 
and emission wavelength 535 nm, using a VictorTM X3 multilabel platereader (Perkin-Elmer, Groningen, 
The Netherlands). Blank data were subtracted from all arbitrary fluorescence units measured and the 
corrected AFU data of the standard range were used to calculate the inulin-FITC concentration of the 
samples (mg/ml). Next, the flux (J) was calculated according to:
= (((( / ) ) )/ )/ = − −⁎ ⁎ · ·J C Mw V t A pmol min cm109 1 2
where C is the calculated concentration (mg/ml), Mw the average inulin-FITC molar mass in mg/mmol 
(4500 mg/mmol), V the volume present in the apical compartment of the perfusion chamber (0.3 ml), t 
the perfusion time (13 min) and A the fiber surface (0.13 cm2).
Functional organic cation transport. The activity of OCT2 in ciPTEC cultured on HFM was exam-
ined real-time by perfusing the hollow fiber basolaterally (inner HFM, (6 ml.h−1,8)) with the fluorescent 
OCT2 substrate 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+, 10 μ M) in KHH buffer, 
when assembled in a microfluidic system. The assay was performed in the presence or absence of a 
cationic uremic toxin mix (UTmix; 10 times uremic plasma concentrations reported in literature - sper-
midine 6.7 μ M, spermine 0.9 μ M, cadaverine 2.1 μ M, putrescine 8.8 μ M, acrolein 14.2 μ M, guanidine 
21.8 μ M and methylguanidine 76.6 μ M)22 or cimetidine (100 μ M), for 13 min at 37 °C, 5% (v/v) CO2. 
Imaging was performed using the Zeiss LSM510 META microscope (Zeiss, Oberkochen, Germany). 
Semi-quantification of real-time data was performed using Image J software (version 1.40 g). Of each 
fiber in time spanning 1–13 min (800 scans), four cells present in the focal plane were used to extract 
mean ASP+ pixel intensities and background was subtracted using pixel intensities form ASP+ perfused 
non-cell double-coated fibers. Next, data were normalized according to:
/ ⁎Y x 100t mt
where Yt is the pixel intentsity at time point t of a condition (ASP+ only, ASP+ + UTmix or ASP+ + 
cimetidine) divided by Xmt , which is the average pixel intensity (m) of only ASP+ condition at that sim-
ilar time point (t). This value was multiplied by 100 and the obtained relative data were fitted according 
to One-phase exponential association using nonlinear regression analysis. To compare ASP+ uptake in 
different conditions, slopes were extracted from min 1–8 and compared. In detail, of each fiber from min 
1–8 (428 scans), four cells present in the focal plane were used to extract mean ASP+ pixel intensities 
and were background corrected. Average pixel intensities from these four cells per fiber were plotted 
and six slopes derived from six fibers per condition were calculated using linear regression analysis and 
compared to ASP+ uptake using two-way ANOVA analysis followed by Bonferroni post-test.
Data analysis. All data are expressed as mean ± S.E.M of multiple replicates. Nonlinear curve fitting 
and statistical analysis of functional organic cation data were performed with GraphPad Prism version 
5.02 (La Jolla, CA). A two-way ANOVA analysis followed by Bonferroni post-test or, when appropriate, 
an unpaired t test was applied. A p-value of < 0.05 was considered significant.
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